tiprankstipranks
Synaptogenix announces FDA approved IND application for Bryostatin-1
PremiumThe FlySynaptogenix announces FDA approved IND application for Bryostatin-1
7M ago
Synaptogenix CEO Dr. Tuchman’s Tenure Extended Through 2024
Premium
Company Announcements
Synaptogenix CEO Dr. Tuchman’s Tenure Extended Through 2024
7M ago
Synaptogenix regains compliance with Nasdaq listing rules
Premium
The Fly
Synaptogenix regains compliance with Nasdaq listing rules
9M ago
Synaptogenix’s Bryostatin-1 in Alzheimer’s featured in peer-reviewed publication
PremiumThe FlySynaptogenix’s Bryostatin-1 in Alzheimer’s featured in peer-reviewed publication
1y ago
Synaptogenix announces findings from independent study on Bryostatin-1
Premium
The Fly
Synaptogenix announces findings from independent study on Bryostatin-1
1y ago
Synaptogenix announces agreement with Cleveland Clinic for Bryostatin-1 trial
Premium
The Fly
Synaptogenix announces agreement with Cleveland Clinic for Bryostatin-1 trial
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100